• iRhythm’s board on Nov. 10, 2026, authorized repurchases of up to $200 million of outstanding common stock.
• Repurchases will be funded with existing cash, cash equivalents and ongoing cash from operations.
• Timing and amounts remain discretionary, depending on market conditions and corporate needs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611111605PRIMZONEFULLFEED9875699) on November 11, 2026, and is solely responsible for the information contained therein.